Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis

Sajad Khazal, Veronika Polishchuk, Gary Soffer, Samantha Prinzing, Jonathan Gill, Kris M. Mahadeo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Primary isolated CNS presentation of HLH is exceedingly rare and typically associated with significant morbidity and mortality. We describe an adolescent patient with late-onset, primary isolated CNS HLH and a compound heterozygous PRF1 mutation (c50delT (p.L17 fs); c.1229G>C (p.R410P)), not previously reported with this phenotype. He was successfully treated with allogeneic HSCT following a reduced-intensity conditioning regimen, despite a high pre-HSCT comorbidity index. Two years after transplant, he is alive and in disease remission. While patients with systemic HLH and active CNS disease have relatively poorer outcomes, a high index of suspicion may aid with early diagnosis of primary isolated CNS HLH; prompt treatment with HSCT may be associated with improved cure and durable remission of this rare disease.

Original languageEnglish (US)
JournalPediatric Transplantation
DOIs
StateAccepted/In press - Jan 1 2017
Externally publishedYes

Fingerprint

Hemophagocytic Lymphohistiocytosis
Hematopoietic Stem Cell Transplantation
Central Nervous System
Central Nervous System Diseases
Rare Diseases
Comorbidity
Early Diagnosis
Morbidity
Transplants
Phenotype
Mutation
Mortality
Therapeutics

Keywords

  • Hematopoietic stem cell transplantation
  • Isolated central nervous system hemophagocytic lymphohistiocytosis
  • Primary hemophagocytic lymphohistiocytosis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis. / Khazal, Sajad; Polishchuk, Veronika; Soffer, Gary; Prinzing, Samantha; Gill, Jonathan; Mahadeo, Kris M.

In: Pediatric Transplantation, 01.01.2017.

Research output: Contribution to journalArticle

@article{d9859cbf5e6c46e39d50d463172d9e7d,
title = "Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis",
abstract = "Primary isolated CNS presentation of HLH is exceedingly rare and typically associated with significant morbidity and mortality. We describe an adolescent patient with late-onset, primary isolated CNS HLH and a compound heterozygous PRF1 mutation (c50delT (p.L17 fs); c.1229G>C (p.R410P)), not previously reported with this phenotype. He was successfully treated with allogeneic HSCT following a reduced-intensity conditioning regimen, despite a high pre-HSCT comorbidity index. Two years after transplant, he is alive and in disease remission. While patients with systemic HLH and active CNS disease have relatively poorer outcomes, a high index of suspicion may aid with early diagnosis of primary isolated CNS HLH; prompt treatment with HSCT may be associated with improved cure and durable remission of this rare disease.",
keywords = "Hematopoietic stem cell transplantation, Isolated central nervous system hemophagocytic lymphohistiocytosis, Primary hemophagocytic lymphohistiocytosis",
author = "Sajad Khazal and Veronika Polishchuk and Gary Soffer and Samantha Prinzing and Jonathan Gill and Mahadeo, {Kris M.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1111/petr.13101",
language = "English (US)",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis

AU - Khazal, Sajad

AU - Polishchuk, Veronika

AU - Soffer, Gary

AU - Prinzing, Samantha

AU - Gill, Jonathan

AU - Mahadeo, Kris M.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Primary isolated CNS presentation of HLH is exceedingly rare and typically associated with significant morbidity and mortality. We describe an adolescent patient with late-onset, primary isolated CNS HLH and a compound heterozygous PRF1 mutation (c50delT (p.L17 fs); c.1229G>C (p.R410P)), not previously reported with this phenotype. He was successfully treated with allogeneic HSCT following a reduced-intensity conditioning regimen, despite a high pre-HSCT comorbidity index. Two years after transplant, he is alive and in disease remission. While patients with systemic HLH and active CNS disease have relatively poorer outcomes, a high index of suspicion may aid with early diagnosis of primary isolated CNS HLH; prompt treatment with HSCT may be associated with improved cure and durable remission of this rare disease.

AB - Primary isolated CNS presentation of HLH is exceedingly rare and typically associated with significant morbidity and mortality. We describe an adolescent patient with late-onset, primary isolated CNS HLH and a compound heterozygous PRF1 mutation (c50delT (p.L17 fs); c.1229G>C (p.R410P)), not previously reported with this phenotype. He was successfully treated with allogeneic HSCT following a reduced-intensity conditioning regimen, despite a high pre-HSCT comorbidity index. Two years after transplant, he is alive and in disease remission. While patients with systemic HLH and active CNS disease have relatively poorer outcomes, a high index of suspicion may aid with early diagnosis of primary isolated CNS HLH; prompt treatment with HSCT may be associated with improved cure and durable remission of this rare disease.

KW - Hematopoietic stem cell transplantation

KW - Isolated central nervous system hemophagocytic lymphohistiocytosis

KW - Primary hemophagocytic lymphohistiocytosis

UR - http://www.scopus.com/inward/record.url?scp=85038018158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038018158&partnerID=8YFLogxK

U2 - 10.1111/petr.13101

DO - 10.1111/petr.13101

M3 - Article

AN - SCOPUS:85038018158

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

ER -